Limited anxiolytic-like effects of non-benzodiazepine hypnotics in rodents

Journal of Psychopharmacology

Volumn 12, Issue 4, 1998, Pages 356-365

  Griebel, Guy ^a   Perrault, Ghislaine ^a   Sanger, David J ^a  

^a SANOFI   (France)

Author keywords

Anxiety; Conflict procedures; Hypnotics; SX 3228; Triazolam; Zaleplon; Zolpidem; Zopiclone

Indexed keywords

BENZODIAZEPINE RECEPTOR STIMULATING AGENT; HYPNOTIC SEDATIVE AGENT; SX 3228; TRIAZOLAM; UNCLASSIFIED DRUG; ZALEPLON; ZOLPIDEM; ZOPICLONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONFLICT; LIGHT DARK CYCLE; MALE; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; TRANQUILIZING ACTIVITY;

EID: 0031743698     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988119801200405     Document Type: Article

References (46)

1. Agnoli A, Manna V, Martucci N (1989) Double-blind study on the hypnotic and antianxiety effects of zopiclone compared with nitrazepam in the treatment of insomnia. Int J Clin Pharmac Res 9: 277-281
2. Barrett J E, Brady L S, Stanley J A, Mansbach R S, Witkin J M (1986) Behavioral studies with anxiolytic drugs. II. Interactions of zopiclone with ethyl-β-carboline-3-carboxylate and Ro 15-1788 in squirrel monkeys. J Pharmac Exp Ther 236: 313-319
3. Bayley P J, Bentley G, Dawson G R (1996) Behavioural evaluation of SX-3228, a potent anticonvulsant. Br J Pharmac 117: 171P
4. Beer B, Ieni J R, Wu W M, Clody D, Amorusi P, Rose J, Mart T, Gaudreault J, Cato A, Stern W (1994) A placebo-controlled evaluation of single, escalating doses of CL 284,846, a non-benzodiazepine hypnotic. J Clin Pharmac 34: 335-344
5. Blanchard J C, Boireau A, Garrett C, Julou L (1979) In vitro and in vivo inhibition by zopiclone of benzodiazepine binding to rodent brain receptors. Life Sci 24: 2417-2420
6. Chaudoir P J, Bodkin N L, O'Donnell J, Anderson A, Holland R L (1990) A comparative study of zopiclone and triazolam in patients with insomnia. Int Clin Psychopharmac 5 (Suppl. 2): 21-27
7. Day I P, Clody D E, Monaghan M M, Abel M S, Dusza J P, Beer B (1992) Pharmacology of CL 284,846, a non-benzodiazepine sedative with reduced amnestic liability. Soc Neurosci Abstr 18: 725
8. Depoortere H, Zivkovic B, Lloyd K G, Sanger D J, Perrault G, Langer S Z, Bartholini G (1986) Zolpidem, a novel non-benzodiazepine hypnotic: I. neuropharmacological and behavioral effects. J Pharmac Exp Ther 237: 649-658
9. Dingemanse J (1995) Pharmacotherapy of insomnia: practice and prospects. Pharm Wld Sci 17: 67-75
10. A receptor. Eur J Pharmac 246: 283-287
11. Freeman H L (1996) Is there a need for a pure hypnotic? Approaches to the co-diagnosis of insomnia and anxiety. J Drug Dev Clin Pract 7: 289-302
12. Goldberg M E, Salama A I, Patel J B, Malick J B (1983) Novel non-benzodiazepine anxiolytics. Neuropharmacology 22: 1499-1504
13. Griebel G, Blanchard D C, Jung A, Blanchard R J (1995) A model of 'antipredator' defense in Swiss-Webster mice: effects of benzodiazepine receptor ligands with different intrinsic activities. Behav Pharmac 6: 732-745
14. Griebel G, Blanchard D C, Blanchard R J (1996a) Evidence that the behaviors in the mouse defense test battery relate to different emotional states: a factor analytic study. Physiol Behav 60: 1255-1260
15. Griebel G, Blanchard D C, Blanchard R J (1996b) Predator-elicited flight responses in Swiss-Webster mice an experimental model of panic attacks. Progr Neuropsychopharm Biol Psychiat 20: 185-205
16. Griebel G, Sanger D J, Perrault G (1996c) Further evidence for differences between non-selective and BZ-1 (ω1) selective, benzodiazepine receptor ligands in murine models of 'state' and 'trait' anxiety. Neuropharmacology 35: 1081-1091
17. Griebel G, Sanger D J, Perrault G (1996d) The use of the rat elevated plus-maze to discriminate between non-selective and BZ-1 (ω1) selective, benzodiazepine receptor ligands. Psychopharmacology 124: 245-254
18. Griebel G, Sanger D J, Perrault G (1996e) The mouse defense test battery: evaluation of the effects of non-selective and BZ-1 (ω1) selective, benzodiazepine receptor ligands. Behav Pharmac 7: 560-572
19. Griebel G, Rodgers R J, Perrault G, Sanger D J (1997a) Risk assessment behaviour: evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test. Pharmac Biochem Behav 57: 817-827
20. Griebel G, Sanger D J, Perrault G (1997b) Genetic differences in the mouse defense test battery. Aggress Behav 23: 19-31
21. Inanaga K, Tanaka M, Mizuki Y (1982) Prediction of clinical efficacy of zopiclone by utilizing two psychophysiological tools in healthy volunteers. Int Pharmacopsychiat 17 (Suppl. 2): 109-115
22. 1A agonistic anxiolytic. Neuropharmacology 30: 475-480
23. Kerr J S, Dawe R A, Parkin C, Hindmarch I (1995) Zopiclone in elderly patients: efficacy and safety. Hum Psychopharmac Clin Exp 10: 221-229
24. Lader M (1986) The use of hypnotics and anxiolytics in the elderly. Int Clin Psychopharmac 1: 273-283
25. Langer S Z, Arbilla S (1988) Imidazopyridines as a tool for the characterization of benzodiazepine receptors: a proposal for a pharmacological classification as ω receptor subtypes. Pharmac Biochem Behav 29: 763-766
26. Langtry H D, Benfield P (1990) Zolpidem. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs 40: 291-313
27. Misslin R, Belzung C, Vogel E (1989) Behavioural validation of a light/dark choice procedure for testing anti-anxiety agents. Behav Process 8: 119-132
28. Mizuki Y, Hashimoto M, Tanaka T, Inanaga K, Tanaka M (1983) A new physiological tool for assessing anxiolytic effects in humans: frontal midline theta activity. Psychopharmacology 80: 311-314
29. Monti J M (1989) Effect of zolpidem on sleep in insomniac patients. Eur J Clin Pharmac 36: 461-466
30. Ohta T (1996) Recent progress in development of psychotropic drugs (5) - hypnotics. Jap J Psychopharmac 16: 161-170
31. Pagot R, Cramer PL, Heritier C, Coquelin J P, Attali P (1993) Comparison of the efficacy and tolerability of zolpidem 20 mg and triazolam 0.5 mg in anxious or depressed insomniac patients. Curr Ther Res Clin Exp 53: 88-97
32. Fellow S, Chopin P, File S E, Briley M (1985) Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Meth 14: 149-167
33. Perrault G, Morel E, Sanger D J, Zivkovic B (1990) Differences in pharmacological profiles of a new generation of benzodiazepine and non-benzodiazepine hypnotics. Eur J Pharmac 187: 487-494
34. Priest R G, Terzano M G, Parrino L, Boyer P (1997) Efficacy of zolpidem in insomnia. Eur Psychiat 12 (Suppl. 1): 5S-14S
35. A receptor α5-subunit creates novel type II benzodiazepine receptor pharmacology. J Neurochem 54: 1802-1804
36. Rodgers R J, Cole J C (1994) The elevated plus-maze: pharmacology, methodology and ethology. In Cooper S J, Hendrie C A (eds), Ethology and psychopharmacology. John Wiley, Chichester
37. Sanger D J (1995) The behavioural effects of novel benzodiazepine (ω) receptor agonists and partial agonists: increases in punished responding and antagonism of the pentylenetetrazole cue. Behav Pharmac 6: 116-126
38. Sanger D J, Zivkovic B (1988) Further behavioural evidence for the selective sedative action of zolpidem. Neuropharmacology 27: 1125-1130
39. Sanger D J, Joly D, Zivkovic B (1985) Behavioral effects of nonbenzodiazepine anxiolytic drugs: a comparison of CGS 9896 and zopiclone with chlordiazepoxide. J Pharmac Exp Ther 232: 831-837
40. Sanger D J, Morel E, Perrault G (1996) Comparison of the pharmacological profiles of the hypnotic drugs, zaleplon and zolpidem. Eur J Pharmac 313: 35-42
41. Stutzmann J M, Piot O, Reibaud M, Doble A, Blanchard J C (1992) Pharmacological properties and mechanism of action of the cyclopyrrolones. Encephale 18: 393-400
42. Ueki S (1987) Behavioral pharmacology of zopiclone. Sleep 10 (Suppl. 1): 1-6
43. Vanover K E, Barrett J E (1994) Evaluation of the discriminative stimulus effects of the novel sedative-hypnotic CL 284,846. Psychopharmacology 115: 289-296
44. Vogel J R, Beer B, Clody D E (1971) A simple and reliable conflict procedure for testing anti-anxiety agents. Psychopharmacologia 21: 1-7
45. Yamamoto T, Ueki S (1987) A new method for screening anxiolytic drugs in rats. Pharmac Biochem Behav 26: 111-117
46. Zivkovic B, Perrault G, Morel E, Sanger D J (1988) Comparative pharmacology of zolpidem and other hypnotics and sleep inducers. In Sauvanet J P, Langer S Z, Morselli P L (eds), Imidazopyridines in sleep disorders. Raven Press, New York